Cited 0 times in Scipus Cited Count

Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma

Authors
Kim, SS  | Nam, JS | Cho, HJ  | Won, JH  | Kim, JW  | Ji, JH  | Yang, MJ  | Park, JH | Noh, CK  | Shin, SJ  | Lee, KM  | Cho, SW  | Cheong, JY
Citation
Journal of gastroenterology and hepatology, 32(1). : 199-207, 2017
Journal Title
Journal of gastroenterology and hepatology
ISSN
0815-93191440-1746
Abstract
BACKGROUND AND AIM: Circulating microRNA (miR)-122 has recently been investigated as a potential biomarker of various hepatic diseases, such as chronic hepatitis and hepatocellular carcinoma (HCC). We investigated the association between plasma miR-122 levels and the treatment outcomes following transarterial chemoembolization (TACE) in HCC patients.
METHODS: We included 177 HCC patients treated with TACE in the study: TACE refractoriness and liver transplantation-free survival were evaluated during follow up. Pretreatment plasma miR-122 levels were assessed using quantitative real-time polymerase chain reaction. Relative quantification of miR-122 expression (fold change) was determined using the 2((-DeltaDeltaCt)) method. MiR-16 was used as an internal control for the normalization of miRNA data.
RESULTS: During the mean follow up of 22.4 (range, 1-79) months, 112 (69.5%) patients exhibited TACE refractoriness. Multivariate analyses showed that tumor number (hazard ratio [HR], 2.51: 95% confidence interval [CI], 1.43-4.41: P = 0.001) and tumor size (HR, 2.65: 95% CI, 1.62-4.32: P = 0.000) can independently predict overall TACE refractoriness. High miR-122 expression (> 100) was associated with early TACE refractoriness (within 1 year: HR, 2.77: 95% CI, 1.12-6.86: P = 0.028), together with tumor number (HR, 22.73: 95% CI, 2.74-188.66: P = 0.004) and tumor size (HR, 4.90: 95% CI, 1.99-12.06: P = 0.001). Univariate analyses showed that high miR-122 expression tends to be associated with poor liver transplantation-free survival (HR, 1.42: 95% CI, 0.95-2.11: P = 0.085). However, it was statistically insignificant in multivariate analysis.
CONCLUSION: High expression levels of plasma miR-122 are associated with early TACE refractoriness in HCC patients treated with TACE.
MeSH

DOI
10.1111/jgh.13448
PMID
27194671
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Gastroenterology
Journal Papers > School of Medicine / Graduate School of Medicine > Radiology
Journal Papers > Research Organization > Genomic Instability Research Center
Ajou Authors
김, 순선  |  김, 진우  |  노, 충균  |  신, 성재  |  양, 민재  |  원, 제환  |  이, 기명  |  정, 재연  |  조, 성원  |  조, 효정  |  지, 재훈
Files in This Item:
There are no files associated with this item.
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse